RU2018107407A3 - - Google Patents

Download PDF

Info

Publication number
RU2018107407A3
RU2018107407A3 RU2018107407A RU2018107407A RU2018107407A3 RU 2018107407 A3 RU2018107407 A3 RU 2018107407A3 RU 2018107407 A RU2018107407 A RU 2018107407A RU 2018107407 A RU2018107407 A RU 2018107407A RU 2018107407 A3 RU2018107407 A3 RU 2018107407A3
Authority
RU
Russia
Application number
RU2018107407A
Other languages
Russian (ru)
Other versions
RU2018107407A (ru
RU2780489C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48141268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2018107407(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2018107407A publication Critical patent/RU2018107407A/ru
Publication of RU2018107407A3 publication Critical patent/RU2018107407A3/ru
Application granted granted Critical
Publication of RU2780489C2 publication Critical patent/RU2780489C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2018107407A 2011-10-21 2012-10-15 Лиофилизированные липосомы RU2780489C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161550047P 2011-10-21 2011-10-21
US61/550,047 2011-10-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014120475A Division RU2648753C2 (ru) 2011-10-21 2012-10-15 Лиофилизированные липосомы

Publications (3)

Publication Number Publication Date
RU2018107407A RU2018107407A (ru) 2019-02-25
RU2018107407A3 true RU2018107407A3 (enExample) 2021-05-04
RU2780489C2 RU2780489C2 (ru) 2022-09-26

Family

ID=

Also Published As

Publication number Publication date
JP2017160211A (ja) 2017-09-14
HUS1900047I1 (hu) 2019-11-28
HK1201039A1 (en) 2015-08-21
JP2020007367A (ja) 2020-01-16
SI2768484T1 (sl) 2019-12-31
JP6359717B2 (ja) 2018-07-18
NL301016I1 (nl) 2019-10-30
AU2012326370A1 (en) 2014-06-05
HRP20191683T1 (hr) 2019-12-13
DK2768484T3 (da) 2019-10-07
KR102113753B1 (ko) 2020-05-21
CA2852777C (en) 2020-10-27
EP2768484A4 (en) 2015-04-22
LUC00135I1 (enExample) 2019-10-25
FR19C1063I1 (fr) 2019-11-22
US20180161273A1 (en) 2018-06-14
NO2019041I1 (no) 2019-11-25
RU2018107407A (ru) 2019-02-25
JP6592556B2 (ja) 2019-10-16
KR20200057104A (ko) 2020-05-25
JP2026102777A (ja) 2026-06-23
KR20140092323A (ko) 2014-07-23
KR20220141906A (ko) 2022-10-20
AU2012326370A2 (en) 2014-06-12
IL232161B (en) 2019-07-31
JP7476161B2 (ja) 2024-04-30
US20210169803A1 (en) 2021-06-10
AU2012326370B2 (en) 2017-06-01
KR20190111139A (ko) 2019-10-01
IL232161A0 (en) 2014-05-28
HUE045978T2 (hu) 2020-01-28
CN108853031A (zh) 2018-11-23
AU2012326370C9 (en) 2023-05-18
FR19C1063I2 (fr) 2020-10-30
PL2768484T3 (pl) 2019-12-31
JP2022033892A (ja) 2022-03-02
NL301016I2 (nl) 2020-04-16
EP2768484A1 (en) 2014-08-27
JP2014532623A (ja) 2014-12-08
KR102024836B1 (ko) 2019-09-24
AU2012326370C1 (en) 2023-03-30
US20230172855A1 (en) 2023-06-08
PT2768484T (pt) 2019-10-28
KR20210095746A (ko) 2021-08-02
US20140255475A1 (en) 2014-09-11
JP6133308B2 (ja) 2017-05-24
US10166184B2 (en) 2019-01-01
CN104114156A (zh) 2014-10-22
KR102452305B1 (ko) 2022-10-07
CA2852777A1 (en) 2013-04-25
ES2750368T3 (es) 2020-03-25
BR112014009305A2 (pt) 2017-04-11
EP2768484B1 (en) 2019-07-24
RU2014120475A (ru) 2015-11-27
LUC00135I2 (enExample) 2021-02-12
US10028912B2 (en) 2018-07-24
BR112014009305B1 (pt) 2023-01-24
WO2013059133A1 (en) 2013-04-25
EP3572071A1 (en) 2019-11-27
US20190070112A1 (en) 2019-03-07
JP2024045183A (ja) 2024-04-02
US10835492B2 (en) 2020-11-17
RU2648753C2 (ru) 2018-03-28
JP2018150342A (ja) 2018-09-27
KR102284689B1 (ko) 2021-08-02

Similar Documents

Publication Publication Date Title
BR112013031251A2 (enExample)
BR112013027245A2 (enExample)
BR112013024383A2 (enExample)
BR112013026905A2 (enExample)
BR112013023185A2 (enExample)
BR112013022995A2 (enExample)
BR112013017670A2 (enExample)
BR112013026744A2 (enExample)
AP3853A (enExample)
BR112013023927A2 (enExample)
BR112013027452A2 (enExample)
BR112013024365A2 (enExample)
BR112013028733A2 (enExample)
BR112013027121A2 (enExample)
AP2016009466A0 (enExample)
BR112013026790A2 (enExample)
BR112013031556A2 (enExample)
BR112013032368A2 (enExample)
BR112013032377A2 (enExample)
BR112013026895A2 (enExample)
BR112013027761A2 (enExample)
BR112013025487A2 (enExample)
BR112013023266A2 (enExample)
BR112013030734A2 (enExample)
BR112013026861A2 (enExample)